mammalian expression and T7 In Vitro Transcription dual vector of SARS-CoV-2 Spike(W152L E484K D614G G769V). Bacterial high copy number plasmid.
Clone info. | mammalian expression and T7 In Vitro Transcription dual vector of SARS-CoV-2 Spike (22017G/T, W152L; 23012G/A, E484K; 23403A/G, D614G; 23868G/T, G769V). Bacterial high copy number plasmid. |
---|---|
Comment | delivative of pT7-KpnI-polyA (RDB19682). |
Vector backbone | pT7-KpnI-pA (RDB19682) (plasmid) |
Growth conditions | LB+amp, 37dC |
Growth remarks | Recommended host, DH5alpha |
Gene/insert name | SARS-CoV-2 Spike genomic DNA. |
Depositor|Developer | DNA Bank, | Nakashima, Kenichi | |
Sequence (full) | RDB19690hts01.seq ![]() |
---|---|
Publication | Unpublished bioresource |
Test sheet | RDB19690C0p1-1.pdf ![]() |
Please check terms and conditions set forth by the depositor, which are specified in the RIKEN BRC Catalog and/or Web Catalog.
Ordering forms | Order form [Credit Card Payment ![]() ![]() ![]() MTA, for use for not-for-profit academic purpose [Word ![]() ![]() Please visit Information of Request for Distribution.[link] For for-profit-research purpose, please contact us. |
---|---|
Terms and conditions for distribution | In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of literature designated by the DEPOSITOR is requested. () |
必要書類 | 提供依頼書 ![]() ![]() 提供同意書 (MTA, 非営利学術目的用)[Word ![]() ![]() 手続きの概要は、「提供申込みについて[link]」をご覧ください。営利目的利用についてはお問い合わせください。 |
---|---|
MTAに書く使用条件 | 利用者は、研究成果の公表にあたって寄託者の指定する文献を引用する()。 |
Catalog # | Resource name | Shipping form | Fee (non-profit org.) |
---|---|---|---|
RDB19690 | pT7-CoV-S(W152L E484K D614G G769V)-pA | DNA solution |
JPY 9,460 (not-for-profit academic purpose) plus cost of shipping containers, dry ice (if required) and shipping charge |
Materials & Methods section:
The pT7-CoV-S(W152L E484K D614G G769V)-pA was provided by the RIKEN BRC through the National BioResource Project of the MEXT, Japan (cat. RDB19690). |
Reference section:
Further references such as user reports and related articles (go to bottom)
Original, user report and related articles
Featured content